(Q39601962)

13 September 2017

title

Effects of intravesical liposome-mediated human beta-defensin-2 gene transfection in a mouse urinary tract infection model (English)

1 reference

13 September 2017

main subject

urinary tract infection

1 reference

Junli Zhao

1

1 reference

13 September 2017

Zhiping Wang

2

1 reference

13 September 2017

Xinnian Chen

3

1 reference

13 September 2017

Jianqin Wang

4

1 reference

13 September 2017

Juan Li

5

1 reference

13 September 2017

publication date

1 April 2011

1 reference

Microbiology and Immunology

13 September 2017

published in

1 reference

13 September 2017

volume

55

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

217-223

1 reference

Urinary tract infections: disease panorama and challenges

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Maintaining a sterile urinary tract: the role of antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Antimicrobial peptides, innate immunity, and the normally sterile urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Innate immunity: from plants to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Human antimicrobial peptides: defensins, cathelicidins and histatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Cationic peptides: a new source of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Defensin participation in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Mouse salivary glands and human beta-defensin-2 as a study model for antimicrobial gene therapy: technical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2011.00315.X

10.1111/J.1348-0421.2011.00315.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference